Fei Xiong is a prominent inventor based in Thousand Oaks, California. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on the development of modified Fc molecules, which have important applications in drug formulation and delivery.

Latest Patents

One of Fei Xiong's latest patents involves a process for preparing pharmacologically active compounds. This process selects at least one internal conjugation site of an Fc domain sequence that is suitable for conjugation with an additional functional moiety. The conjugation is achieved through defined chemistry involving the side chain of an amino acid residue at the conjugation site. The technology allows for the addition of appropriate amino acid residues, either by insertion or replacement, to enhance the functionality of the Fc domain. This innovative approach can lead to the production of useful compositions of matter and pharmaceutical formulations. Additionally, the patent includes a DNA encoding the inventive composition, an expression vector containing the DNA, and a host cell that carries the expression vector.

Career Highlights

Fei Xiong is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Amgen has positioned him as a key player in the development of advanced pharmaceutical solutions.

Collaborations

Fei Xiong collaborates with notable colleagues, including Colin V Gegg and Karen C Sitney. These partnerships enhance the research and development efforts within the company, contributing to the advancement of pharmaceutical technologies.

Conclusion

Fei Xiong's innovative work in the field of pharmaceuticals, particularly in the development of modified Fc molecules, showcases his expertise and commitment to advancing medical science. His contributions are paving the way for new therapeutic options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.